Page 13 - 2022-35-中国全科医学
P. 13
·4362· http://www.chinagp.net E-mail:zgqkyx@chinagp.net.cn
[12]CROSSINGHAM I,TURNER S,RAMAKRISHNAN S,et al. 761-767. DOI:10.1136/thx.2007.089193.
Combination fixed-dose beta agonist and steroid inhaler as required [25]SHIRTCLIFFE P,MARSH S,TRAVERS J,et al. Childhood
for adults or children with mild asthma[J]. Cochrane Database asthma and GOLD-defined chronic obstructive pulmonary
Syst Rev,2021,5(5):CD013518. DOI:10.1002/14651858. disease[J]. Intern Med J,2012,42(1):83-88. DOI:
CD013518.pub2. 10.1111/j.1445-5994.2010.02238.x.
[13]FITZGERALD J M,O'BYRNE P M,BATEMAN E D,et al. [26]GUERRA S,SHERRILL D L,KURZIUS-SPENCER M,et al.
Safety of as-needed budesonide-formoterol in mild asthma:data The course of persistent airflow limitation in subjects with and
from the two phase Ⅲ SYGMA studies[J]. Drug Saf,2021, without asthma[J]. Respir Med,2008,102(10):1473-
44(4):467-478. DOI:10.1007/s40264-020-01041-z. 1482. DOI:10.1016/j.rmed.2008.04.011.
[14]CORREN J,PARNES J R,WANG L W,et al. Tezepelumab [27]SILVA G E,SHERRILL D L,GUERRA S,et al. Asthma as a risk
in adults with uncontrolled asthma[J]. N Engl J Med,2017, factor for COPD in a longitudinal study[J]. Chest,2004,126(1):
377(10):936-946. DOI:10.1056/NEJMoa1704064. 59-65. DOI:10.1378/chest.126.1.59.
[15]KENDZERSKA T,SADATSAFAVI M,AARON S D,et al. [28]VAN SCHAYCK C P,LEVY M L,CHEN J C,et al. Coordinated
diagnostic approach for adult obstructive lung disease in primary
Concurrent physician-diagnosed asthma and chronic obstructive
care[J]. Prim Care Respir J,2004,13(4):218-221. DOI:
pulmonary disease:a population study of prevalence,incidence
10.1016/j.pcrj.2004.07.001.
and mortality[J]. PLoS One,2017,12(3):e0173830.
[29]ZEKI A A,SCHIVO M,CHAN A,et al. The asthma-
DOI:10.1371/journal.pone.0173830.
COPD overlap syndrome:a common clinical problem in the
[16]UCHIDA A,SAKAUE K,INOUE H. Epidemiology of asthma-
elderly[J]. J Allergy (Cairo),2011,2011:861926. DOI:
chronic obstructive pulmonary disease overlap (ACO)[J].
10.1155/2011/861926.
Allergol Int,2018,67(2):165-171. DOI:10.1016/j.
[30]LOUIE S,ZEKI A A,SCHIVO M,et al. The asthma-
alit.2018.02.002.
chronic obstructive pulmonary disease overlap syndrome:
[17]KRISHNAN J A,NIBBER A,CHISHOLM A,et al. Prevalence
pharmacotherapeutic considerations[J]. Expert Rev Clin
and characteristics of asthma-chronic obstructive pulmonary
Pharmacol,2013,6(2):197-219. DOI:10.1586/ecp.13.2.
disease overlap in routine primary care practices[J]. Ann
[31]GERSHON A S,CAMPITELLI M A,CROXFORD R,et al.
Am Thorac Soc,2019,16(9):1143-1150. DOI:
Combination long-acting β-agonists and inhaled corticosteroids
10.1513/AnnalsATS.201809-607OC.
compared with long-acting β-agonists alone in older adults with
[18]BARRECHEGUREN M,PINTO L,MOSTAFAVI-POUR-
chronic obstructive pulmonary disease[J]. JAMA,2014,
MANSHADI S M,et al. Identification and definition of asthma-
312(11):1114-1121. DOI:10.1001/jama.2014.11432.
COPD overlap:the CanCOLD study[J]. Respirology,2020,25
[32]WILLIAMSON E J,WALKER A J,BHASKARAN K,
(8):836-849. DOI:10.1111/resp.13780.
et al. Factors associated with COVID-19-related death using
[19]ALSHABANAT A,ZAFARI Z,ALBANYAN O,et al. Asthma
OpenSAFELY[J]. Nature,2020,584(7821):430-436.
and COPD overlap syndrome (ACOS):a systematic review and
DOI:10.1038/s41586-020-2521-4.
meta analysis[J]. PLoS One,2015,10(9):e0136065.
[33]VIRANT F S,RANDOLPH C,NANDA A,et al. Pulmonary
DOI:10.1371/journal.pone.0136065.
procedures during the COVID-19 pandemic:a work group report
[20]GIBSON P G,SIMPSON J L. The overlap syndrome of
of the AAAAI asthma diagnosis and treatment (ADT) interest
asthma and COPD:what are its features and how important
section[J]. J Allergy Clin Immunol Pract,2022,10(6):
is it? [J]. Thorax,2009,64(8):728-735. DOI:
1474-1484. DOI:10.1016/j.jaip.2022.02.044.
10.1136/thx.2008.108027.
[34]DING B,SMALL M. Disease burden of mild asthma in
[21]ANDERSEN H,LAMPELA P,NEVANLINNA A,et al. High China[J]. Respirology,2018,23(4):369-377. DOI:
hospital burden in overlap syndrome of asthma and COPD[J]. Clin 10.1111/resp.13189.
Respir J,2013,7(4):342-346. DOI:10.1111/crj.12013. [35]林江涛,王文巧,周新,等 . 我国中心城市支气管哮喘患者急
[22]ABRAMSON M J,SCHATTNER R L,SULAIMAN N D,et al. 性发作征兆及其自我管理水平的调查分析[J]. 中华医学杂志,
Accuracy of asthma and COPD diagnosis in Australian general 2017,97(30):2329-2332.
practice:a mixed methods study[J]. Prim Care Respir J, LIN J T,WANG W Q,ZHOU X,et al. Warning symptoms of
2012,21(2):167-173. DOI:10.4104/pcrj.2011.00103. asthma attack and asthma self-management:a national asthma
[23]MANNINO D M,GAGNON R C,PETTY T L,et al. Obstructive control survey from China[J]. National Medical Journal of China,
lung disease and low lung function in adults in the United States: 2017,97(30):2329-2332.
data from the National Health and Nutrition Examination Survey, [36]中华医学会呼吸病学分会哮喘学组.支气管哮喘防治指南(2020
1988-1994[J]. Arch Intern Med,2000,160(11):1683- 年版)[J]. 中华结核和呼吸杂志,2020,43(12):1023-
1689. DOI:10.1001/archinte.160.11.1683. 1048. DOI:10.3760/cma.j.cn112147-20200618-00721.
[24]MARSH S E,TRAVERS J,WEATHERALL M,et al. Proportional (收稿日期:2022-06-22;修回日期:2022-07-17)
classifications of COPD phenotypes[J]. Thorax,2008,63(9): (本文编辑:崔莎)